Evidence map›Paper›PMID 32827010›Full record

ArticleJNMA; journal of the Nepal Medical Association2020

Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report.

Ayush Adhikari, Ram Chandra Subedi, Subi Acharya, Raju Paudel

Open access · diamondAbstract readCase Reports
In one paragraph

Article in JNMA; journal of the Nepal Medical Association, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ayush AdhikariDepartment of Medicine, Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
Ram Chandra SubediDepartment of Medicine, Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
Subi AcharyaDepartment of Medicine, Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
Raju PaudelDepartment of Medicine, Shree Birendra Hospital, Chhauni, Kathmandu, Nepal.
Bir Hospital · NP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-Leucine-rich glioma-inactivated-1 encephalitis is a subtype of autoimmune encephalitis characterized by cognitive impairment, faciobrachial dystonic seizures, and behavioural changes. There is no reported case from Nepal. We report a case of a 54-year old male who presented with abnormal body movement, behavioural changes, rapid eye movement sleep behavioural changes, and cognitive decline. Investigations revealed magnetic resonance imaging findings of fluidattenuated inversion recovery intensity signal in bilateral temporal lobes with anti-leucine-rich glioma-inactivated-1 antibody in serum leading to diagnosis of anti-leucine-rich glioma-inactivated-1 encephalitis. He was treated with steroids and intravenous immunoglobulin. Timely diagnosis is vital to prevent complications and improve outcomes.

Indexed as

Intracellular Signaling Peptides and ProteinsLimbic EncephalitisMental DisordersAnticonvulsantsAutoantibodiesAutoimmune Diseases of the Nervous SystemCognitive DysfunctionDystonic DisordersGlucocorticoidsHumansImmunoglobulins, IntravenousMagnetic Resonance ImagingMaleMethylprednisoloneMiddle AgedNepalAnticonvulsantsAutoantibodiesGlucocorticoidsImmunoglobulins, IntravenousIntracellular Signaling Peptides and ProteinsLGI1 protein, humanMethylprednisoloneanti-LGI1; autoimmune; faciobrachial seizures; limbic.

Identifiers

PMID32827010
PMCPMC7580401
OpenAlexW3080423272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.